Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT

被引:0
作者
Pierpaolo Alongi
Maria Picchio
Fabio Zattoni
Marianna Spallino
Luigi Gianolli
Giorgio Saladini
Laura Evangelista
机构
[1] IRCCS San Raffaele Scientific Institute,Nuclear Medicine Department
[2] University of Padua,Department of Oncological and Surgical Sciences, Urology Clinic
[3] University of Milano-Bicocca,Radiotherapy and Nuclear Medicine Unit
[4] Veneto Institute of Oncology IOV - IRCCS,undefined
[5] Padua,undefined
[6] Italy,undefined
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2016年 / 43卷
关键词
Renal cell carcinoma; FDG PET/CT; Prognosis; Recurrence; Multivariate analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:464 / 473
页数:9
相关论文
共 144 条
  • [1] Escudier B(2014)Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 25 iii49-56
  • [2] Porta C(2007)Estimates of the cancer incidence and mortality in Europe in 2006 Ann Oncol 18 581-92
  • [3] Schmidinger M(2009)Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma J Clin Oncol 27 3584-90
  • [4] Algaba F(2009)Renal cell carcinoma Lancet 373 1119-32
  • [5] Patard JJ(1969)The results of radical nephrectomy for renal cell carcinoma J Urol 101 297-301
  • [6] Khoo V(1999)Prognostic factors in renal cell and bladder cancer BJU Int 83 902-8
  • [7] Ferlay J(2010)Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients Eur Urol 57 317-25
  • [8] Autier P(1999)Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis Eur Urol 35 197-203
  • [9] Boniol M(2010)The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM Ann Surg Oncol 17 1471-4
  • [10] Heanue M(2003)Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials Cancer 97 1663-71